H. Todo et al., Effect of additives on insulin absorption from intratracheally administered dry powders in rats, INT J PHARM, 220(1-2), 2001, pp. 101-110
The lungs are useful for administration of macromolecules, which are poorly
absorbed from the intestine. In the present study, we prepared several dry
powder formulations of insulin using a spray drying technique to examine t
he effect of additives on insulin absorption. The bioavailability of insuli
n was estimated from the change in the plasma glucose level. The bioavailab
ility of insulin from dry powder with no additive exceeded that obtained fr
om pH 7.4 solution. The absolute bioavailability of insulin administered as
a solution with 1.4 mg/dose of bacitracin or 1.0 mg/dose of Span 85 was al
most 100%. The bioavailability of dry powder with 0.42 mg/dose of bacitraci
n was 20% that of the solution with 1.4 mg/dose of bacitracin. The insulin
dry powder with 0.21 mg/dose of Spall 85 showed a bioavailability less than
that for the insulin solution with 0.1 mg/dose of Span 85. Bacitracin and
Span 85 were not as effective in dry powder as in solution in the present s
tudy. While citric acid was more effective in dry powder that in solution t
o increase the hypoglycemic effect. The pH 5.0 and pH 3.0 solutions contain
ing 0.19 mg of citric acid in 0.1 ml showed absolute bioavailabilities of 4
3% and 57%, respectively, while the bioavailabilities for dry powders conta
ining 0.025 and 0.036 mg/dose citric acid were 42%, and 53%, respectively.
In addition, the hypoglycemic effect of dry powders continued for a longer
period and remained at 240 min with the dry powders, while it disappeared a
t 180 min with the solutions. When the insulin dry powder containing 0.036
mg/dose of citric acid was administered, the lactate dehydrogenase activity
, a sensitive indicator of acute toxicity to lung cells, in bronchoalveolar
lavage was as low as that fur saline administration, suggesting citric aci
d is a safe additive. Thus, citric acid appears to be a safe and potent abs
orption enhancer for insulin in dry powder. (C) 2001 Elsevier Science B.V.
All rights reserved.